European equities traded in the US as American depositary receipts were falling Friday morning, down 1.3% to 1,489.59 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech company Cellectis (CLLS) and oil and gas company Equinor (EQNR), which rose 4.6% and 4.1%, respectively.
They were followed by late-stage biopharmaceutical company Genfit (GNFT), which was up 2.9%.
The decliners from continental Europe were led by biotech company Evaxion (EVAX) and cybersecurity firm Wisekey (WKEY), which fell 5.9% and 5.2%, respectively.
They were followed by biotech company Abivax (ABVX), down 5.1%, and semiconductor company ASML (ASML), shedding 2.8%.
From the UK and Ireland, the gainers were led by energy giant BP (BP) and cigarette company British American Tobacco (BTI), which rose 2.1% and 1%, respectively.
The decliners from the UK and Ireland were led by cruise operator Carnival (CUK) and biotech company Bicycle Therapeutics (BCYC), which were shedding 4.5% and 4.3%, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.